Recent years have witnessed groundbreaking developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://junaidnwce373727.blogolenta.com/36002621/exploring-the-future-of-type-2-diabetes-treatment-retatrutide-and-trizepatide